RPG Life Sciences Limited Financial Overview
RPG Life Sciences Limited's market cap is currently ₹38.83B. The company's EPS TTM is ₹22.281; its P/E ratio is 18.02; and it has a dividend yield of 0.85%. RPG Life Sciences Limited is scheduled to report earnings on October 17, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.